0.3715
-0.0008
(-0.21%)
At close: 8:08:28 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | 24.91M | -- | 177.85M | 166.15M |
| Low Estimate | 24M | -- | 177M | 145M |
| High Estimate | 25.82M | -- | 178.7M | 187.3M |
| Year Ago Sales | 27.14M | -- | 147.75M | 177.85M |
| Sales Growth (year/est) | -8.21% | -- | 20.37% | -6.58% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1FG.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/20/2025 |
| Downgrade | B of A Securities: Neutral to Underperform | 8/8/2023 |
| Maintains | Goldman Sachs: Sell to Sell | 6/27/2023 |
| Downgrade | Raymond James: Outperform to Market Perform | 6/27/2023 |
| Downgrade | B of A Securities: Buy to Neutral | 6/26/2023 |
| Downgrade | Stifel: Buy to Hold | 6/26/2023 |
Related Tickers
NB11.F Vaxart, Inc.
0.4818
-1.79%
MBIO.CN MindBio Therapeutics Corp.
0.0200
+33.33%
ARTL Artelo Biosciences, Inc.
1.0000
-6.54%
ATXS Astria Therapeutics, Inc.
6.10
-5.28%
SCPX Scorpius Holdings, Inc.
0.1621
-5.20%
CTMX CytomX Therapeutics, Inc.
0.6503
-3.97%
ALLR Allarity Therapeutics, Inc.
0.8801
+10.19%
NKTR Nektar Therapeutics
0.8019
-4.54%
RENB Renovaro Inc.
0.8937
-9.05%
CDT Conduit Pharmaceuticals Inc.
1.1600
-3.33%